These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 12580114)
1. [Effect of pH on the permeability of timolol maleate across isolated rabbit cornea]. Wei G; Xu H; Ma Y; Li SM; Zheng JM Yao Xue Xue Bao; 2001 Sep; 36(9):707-10. PubMed ID: 12580114 [TBL] [Abstract][Full Text] [Related]
2. Novel ophthalmic timolol meleate liposomal-hydrogel and its improved local glaucomatous therapeutic effect in vivo. Zhang HH; Luo QH; Yang ZJ; Pan WS; Nie SF Drug Deliv; 2011; 18(7):502-10. PubMed ID: 21790329 [TBL] [Abstract][Full Text] [Related]
3. Development of cultured rabbit corneal epithelium for drug permeation studies: a comparison with excised rabbit cornea. Burgalassi S; Monti D; Brignoccoli A; Fabiani O; Lenzi C; Pirone A; Chetoni P J Ocul Pharmacol Ther; 2004 Dec; 20(6):518-32. PubMed ID: 15684811 [TBL] [Abstract][Full Text] [Related]
4. Promoting effect of borneol on the permeability of puerarin eye drops and timolol maleate eye drops through the cornea in vitro. Wu CJ; Huang QW; Qi HY; Guo P; Hou SX Pharmazie; 2006 Sep; 61(9):783-8. PubMed ID: 17020156 [TBL] [Abstract][Full Text] [Related]
5. Cell culture models of the human cornea - a comparative evaluation of their usefulness to determine ocular drug absorption in-vitro. Reichl S J Pharm Pharmacol; 2008 Mar; 60(3):299-307. PubMed ID: 18284809 [TBL] [Abstract][Full Text] [Related]
6. Improvement of the ocular bioavailability of timolol by sorbic acid. Higashiyama M; Inada K; Ohtori A; Tojo K Int J Pharm; 2004 Mar; 272(1-2):91-8. PubMed ID: 15019072 [TBL] [Abstract][Full Text] [Related]
7. Liposome incorporated ion sensitive in situ gels for opthalmic delivery of timolol maleate. Yu S; Wang QM; Wang X; Liu D; Zhang W; Ye T; Yang X; Pan W Int J Pharm; 2015 Mar; 480(1-2):128-36. PubMed ID: 25615987 [TBL] [Abstract][Full Text] [Related]
8. Beta-adrenergic blockers: ocular penetration and binding to the uveal pigment. Araie M; Takase M; Sakai Y; Ishii Y; Yokoyama Y; Kitagawa M Jpn J Ophthalmol; 1982; 26(3):248-63. PubMed ID: 6130180 [TBL] [Abstract][Full Text] [Related]
10. Permeability characteristics of novel mydriatic agents using an in vitro cell culture model that utilizes SIRC rabbit corneal cells. Goskonda VR; Khan MA; Hutak CM; Reddy IK J Pharm Sci; 1999 Feb; 88(2):180-4. PubMed ID: 9950635 [TBL] [Abstract][Full Text] [Related]
11. Effect of chitosan, benzalkonium chloride and ethylenediaminetetraacetic acid on permeation of acyclovir across isolated rabbit cornea. Majumdar S; Hippalgaonkar K; Repka MA Int J Pharm; 2008 Feb; 348(1-2):175-8. PubMed ID: 17897799 [TBL] [Abstract][Full Text] [Related]
12. The relations between ionic and non-ionic diffusion of sulfonamides across the rabbit cornea. Jankowska LM; Bar-Ilan A; Maren TH Invest Ophthalmol Vis Sci; 1986 Jan; 27(1):29-37. PubMed ID: 3941035 [TBL] [Abstract][Full Text] [Related]
13. Change in corneal permeability to timolol after laser in situ keratomileusis and photorefractive keratectomy in rabbit. Hamada N; Amano S; Yamagami S; Araie M; Oshika T; Wada T; Miyai H; Notsu Y Jpn J Ophthalmol; 2005; 49(1):12-4. PubMed ID: 15692768 [TBL] [Abstract][Full Text] [Related]
14. The transcorneal penetration of commercial ophthalmic formulations containing timolol maleate in rabbit eyes. Fukuda M; Sasaki H J Ocul Pharmacol Ther; 2015 Feb; 31(1):57-60. PubMed ID: 25303115 [TBL] [Abstract][Full Text] [Related]
15. The role of hyaluronan as a drug carrier to enhance the bioavailability of extended release ophthalmic formulations. Hyaluronan-timolol ionic complexes as a model case. Battistini FD; Tártara LI; Boiero C; Guzmán ML; Luciani-Giaccobbe LC; Palma SD; Allemandi DA; Manzo RH; Olivera ME Eur J Pharm Sci; 2017 Jul; 105():188-194. PubMed ID: 28506871 [TBL] [Abstract][Full Text] [Related]
17. In vivo evaluation and in-depth pharmaceutical characterization of a rapidly dissolving solid ocular matrix for the topical delivery of timolol maleate in the rabbit eye model. Moosa RM; Choonara YE; du Toit LC; Tomar LK; Tyagi C; Kumar P; Carmichael TR; Pillay V Int J Pharm; 2014 May; 466(1-2):296-306. PubMed ID: 24607446 [TBL] [Abstract][Full Text] [Related]
18. Human cornea construct HCC-an alternative for in vitro permeation studies? A comparison with human donor corneas. Reichl S; Döhring S; Bednarz J; Müller-Goymann CC Eur J Pharm Biopharm; 2005 Jul; 60(2):305-8. PubMed ID: 15939241 [TBL] [Abstract][Full Text] [Related]
19. Cultivation and characterization of a bovine in vitro model of the cornea. Tegtmeyer S; Reichl S; Müller-Goymann CC Pharmazie; 2004 Jun; 59(6):464-71. PubMed ID: 15248462 [TBL] [Abstract][Full Text] [Related]
20. Ocular toxicity of some corneal penetration enhancers evaluated by electrophysiology measurements on isolated rabbit corneas. Chetoni P; Burgalassi S; Monti D; Saettone MF Toxicol In Vitro; 2003 Aug; 17(4):497-504. PubMed ID: 12849734 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]